- Sections
- C - Chimiemétallurgie
- C07D - Composés hétérocycliques
- C07D 233/92 - Radicaux nitro liés en position 4 ou 5
Détention brevets de la classe C07D 233/92
Brevets de cette classe: 28
Historique des publications depuis 10 ans
|
1
|
2
|
2
|
4
|
1
|
2
|
1
|
2
|
0
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| H. Lee Moffitt Cancer Center and Research Institute, Inc. | 971 |
3 |
| Otsuka Pharmaceutical Co., Ltd. | 1496 |
3 |
| Dynamit Nobel GmbH Explosivstoff-und Systemtechnik | 13 |
2 |
| F. Hoffmann-La Roche AG | 7947 |
1 |
| Bayer Cropscience AG | 2009 |
1 |
| Murata Manufacturing Co., Ltd. | 24829 |
1 |
| Board of Regents, The University of Texas System | 5884 |
1 |
| The Trustees of the University of Pennsylvania | 4354 |
1 |
| National Institute of Advanced Industrial Science and Technology | 3801 |
1 |
| Asahi Kasei Chemicals Corporation | 655 |
1 |
| Eli Lilly and Company | 3908 |
1 |
| Eth Zurich | 1290 |
1 |
| Immunomet Therapeutics Inc. | 31 |
1 |
| Nanjing Sanhome Pharmaceutical Co., Ltd. | 63 |
1 |
| New Form Pharmaceuticals Inc. | 1 |
1 |
| Nippon Soda Co., Ltd. | 892 |
1 |
| Shikoku Chemicals Corporation | 94 |
1 |
| St. Jude Children's Research Hospital, Inc. | 222 |
1 |
| Taiyo Nippon Sanso Corporation | 363 |
1 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2882 |
1 |
| Autres propriétaires | 3 |